- Home
- SVRA vs CBL Comparison
SVRA vs CBL Comparison
Compare SVRA & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | CBL |
|---|---|---|
| Founded | 2007 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2009 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SVRA | CBL |
|---|---|---|
| Price | $5.13 | $44.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $7.33 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.2M | 157.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | N/A | ★ 132.09 |
| EPS | N/A | ★ 4.34 |
| Revenue | N/A | ★ $578,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $430.87 | N/A |
| P/E Ratio | ★ N/A | $10.40 |
| Revenue Growth | N/A | ★ 12.18 |
| 52 Week Low | $1.89 | $23.92 |
| 52 Week High | $7.01 | $45.45 |
Technical Indicators
Market Signals| Indicator | SVRA | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 73.55 |
| Support Level | $4.95 | $36.41 |
| Resistance Level | $6.15 | N/A |
| Average True Range (ATR) | 0.29 | 0.98 |
| MACD | -0.09 | 0.20 |
| Stochastic Oscillator | 16.85 | 83.93 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.